CYCLERION THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
CYCLERION THERAPEUTICS, INC. (CYCN) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2025-11-12
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-09-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2024-03-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$213.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$366.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was -$366.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 | $0.00 10-K/A · filed 2025-11-12 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 | -$31.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | -$31.00K derived: sum of 3 quarters · filed 2025-11-12 | -$122.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | -$31.00K derived: sum of 2 quarters · filed 2025-11-12 | -$122.00K derived: sum of 3 quarters · filed 2025-11-12 | -$213.00K 10-K/A · filed 2025-11-12 | |
| 2023-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$122.00K derived: sum of 2 quarters · filed 2024-11-14 | -$213.00K 10-Q · filed 2024-11-14 | -$305.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$182.00K 10-Q · filed 2024-08-07 | -$274.00K derived: sum of 3 quarters · filed 2024-08-07 | -$365.00K derived: sum of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | -$91.00K 10-Q · filed 2024-05-07 | -$183.00K derived: sum of 2 quarters · filed 2024-05-07 | -$274.00K derived: sum of 3 quarters · filed 2024-05-07 | -$366.00K derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | -$92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$183.00K derived: sum of 2 quarters · filed 2024-03-05 | -$275.00K derived: sum of 3 quarters · filed 2024-03-05 | -$366.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$183.00K derived: sum of 2 quarters · filed 2023-11-13 | -$274.00K 10-Q · filed 2023-11-13 | -$366.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$183.00K 10-Q · filed 2023-07-28 | -$275.00K derived: sum of 3 quarters · filed 2023-07-28 | -$366.00K derived: sum of 4 quarters · filed 2023-07-28 | |
| 2022-03-31 | -$91.00K 10-Q · filed 2023-05-12 | -$183.00K derived: sum of 2 quarters · filed 2023-05-12 | -$274.00K derived: sum of 3 quarters · filed 2023-05-12 | -$366.00K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$183.00K derived: sum of 2 quarters · filed 2023-03-22 | -$275.00K derived: sum of 3 quarters · filed 2023-03-22 | -$366.00K 10-K · filed 2023-03-22 | $366.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$183.00K derived: sum of 2 quarters · filed 2022-11-03 | -$274.00K 10-Q · filed 2022-11-03 | -$2.14M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$183.00K 10-Q · filed 2022-08-09 | -$2.05M derived: sum of 3 quarters · filed 2022-08-09 | -$1.92M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$91.00K 10-Q · filed 2022-05-04 | -$1.96M derived: sum of 2 quarters · filed 2022-05-04 | -$1.83M derived: sum of 3 quarters · filed 2022-05-04 | -$1.50M derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$1.74M derived: sum of 2 quarters · filed 2022-02-24 | -$1.41M derived: sum of 3 quarters · filed 2022-02-24 | -$888.00K 10-K · filed 2022-02-24 | $888.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $460.00K derived: sum of 2 quarters · filed 2021-11-09 | $979.00K 10-Q · filed 2021-11-09 | $1.52M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $851.00K 10-Q · filed 2021-07-29 | $1.39M derived: sum of 3 quarters · filed 2021-07-29 | $1.39M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2020-03-31 | $519.00K 10-Q · filed 2021-04-30 | $1.06M derived: sum of 2 quarters · filed 2021-04-30 | $1.06M derived: sum of 3 quarters · filed 2021-04-30 | $1.04M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-12-31 | $540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $540.00K derived: sum of 2 quarters · filed 2021-02-25 | $521.00K derived: sum of 3 quarters · filed 2021-02-25 | $515.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$19.00K derived: sum of 2 quarters · filed 2020-11-05 | -$25.00K 10-Q · filed 2020-11-05 | -$36.00K derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | -$25.00K 10-Q · filed 2020-08-03 | -$36.00K derived: sum of 3 quarters · filed 2020-08-03 | -$49.00K derived: sum of 4 quarters · filed 2020-08-03 | |
| 2019-03-31 | -$6.00K 10-Q · filed 2020-05-04 | -$17.00K derived: sum of 2 quarters · filed 2020-05-04 | -$30.00K derived: sum of 3 quarters · filed 2020-05-04 | -$43.00K derived: sum of 4 quarters · filed 2020-05-04 | |
| 2018-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$24.00K derived: sum of 2 quarters · filed 2020-03-12 | -$37.00K derived: sum of 3 quarters · filed 2020-03-12 | -$55.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$26.00K derived: sum of 2 quarters · filed 2019-11-12 | -$44.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$31.00K 10-Q · filed 2019-08-12 | |||
| 2018-03-31 | -$18.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |